Radical Lymph Node Dissection in Primary Esophagectomy for Esophageal Squamous Cell Carcinoma

被引:25
|
作者
Lin, Chen-Sung
Cheng, Chih-Tao
Liu, Chao-Yu
Lee, Ming-Yuan
Hsiao, Mu-Chi
Shih, Chih-Hsun
Liu, Chia-Chuan
机构
[1] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan
[2] Natl Def Univ, Taipei, Taiwan
[3] Far Eastern Mem Hosp, Div Thorac Surg, New Taipei City, Taiwan
[4] Taipei Hosp, Minist Hlth & Welf, Div Thorac Surg, New Taipei City, Taiwan
[5] Koo Fdn Sun Yat Sen Canc Ctr, Dept Pathol, Taipei 112, Taiwan
[6] Koo Fdn Sun Yat Sen Canc Ctr, Div Thorac Surg & Psychiat, Taipei 112, Taiwan
来源
ANNALS OF THORACIC SURGERY | 2015年 / 100卷 / 01期
关键词
CANCER-PATIENTS; NUMBER; IMPACT; LYMPHADENECTOMY; SURVIVAL;
D O I
10.1016/j.athoracsur.2015.02.053
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Subtotal esophagectomy with radical lymph node dissection (RLND) remains an effective therapeutic strategy for localized esophageal squamous cell carcinoma (ESCC). However, controversy exists regarding the extent to which RLND should be performed. We reappraised the prognostic impact and accurate nodal staging of RLND in ESCC. Methods. The data from 101 ESCC patients (mean age, 57.5 years; 93 men) who underwent primary subtotal esophagectomy were retrospectively collected. Candidate variables, including the number of total dissected lymph nodes (TDLN [subgrouped into TDLN less than 13, TDLN 13 to 40, and TDLN more than 40]), were evaluated to determine their prognostic impacts and hazard ratio (HR). Results. Fewer TDLN (p < 0.001; HR 9.011, 2.449, and 1.000 for TDLN less than 13, TDLN 13 to 40, and TDLN more than 40, respectively), tumor length exceeding 3.5 cm (p < 0.001; HR 3.321), resection margin invasion (p < 0.001; HR 14.493), and positive nodal status (p = 0.002; HR 2.730) were independent predictors of a poor prognosis. Considering the 54 node-negative patients, more TDLN correlated with improved survival (p = 0.001). Risk analysis demonstrated that one fewer TDLN could contribute to an increased HR of 1.047 (p = 0.014). However, RLND involving more TDLN appeared to lose the prognostic impact for the 47 node-positive patients (p = 0.072). Furthermore, the number of positive dissected lymph nodes remained at approximately 4 if the number of TDLN exceeded 20. Conclusions. For N-negative or N-positive ESCC patients undergoing primary surgical resection, the number of TDLN influenced their prognosis or nodal staging accuracy, respectively. At least 20 TDLN were necessary for N-positive patients. (C) 2015 by The Society of Thoracic Surgeons
引用
收藏
页码:278 / 287
页数:11
相关论文
共 50 条
  • [1] Combined endoscopic-laparoscopic radical esophagectomy and lymph node dissection for the treatment of esophageal squamous cell carcinoma
    Wang, Guojun
    Liu, Bing-Rong
    Hu, Zhihao
    [J]. GASTROINTESTINAL ENDOSCOPY, 2020, 91 (01) : 192 - 193
  • [2] Lymph Node Dissection for Esophageal Squamous Cell Carcinoma
    Hsu, Po-Kuei
    Lee, Yi-Ying
    Chuang, Lin -Chi
    Wu, Yu -Chung
    [J]. THORACIC SURGERY CLINICS, 2022, 32 (04) : 497 - 510
  • [3] Recurrence patterns and risk factors following thoracoscopic esophagectomy with radical lymph node dissection for thoracic esophageal squamous cell carcinoma
    Ninomiya, Itasu
    Okamoto, Koichi
    Tsukada, Tomoya
    Kinoshita, Jun
    Oyama, Katsunobu
    Fushida, Sichio
    Osugi, Harushi
    Ohta, Tetsuo
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (02) : 278 - 284
  • [4] Clinical and Pathologic Supraclavicular Lymph Node Metastases in Esophageal Squamous Cell Carcinoma Treated by Esophagectomy with Three-Field Lymph Node Dissection
    Park, Seong Yong
    Lee, Junghee
    Jeon, Yeong Jeong
    Cho, Jong Ho
    Kim, Hong Kwan
    Choi, Yong Soo
    Zo, Jae Il
    Shim, Young Mog
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 31 (5) : 3399 - 3408
  • [5] Outcomes of cervical lymph node recurrence in patients with esophageal squamous cell carcinoma after esophagectomy with 2-field lymph node dissection
    Lee, Deok Heon
    Kim, Hyeong Ryul
    Kim, Dong Kwan
    Park, Seung-Il
    Kim, Yong-Hee
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 146 (02): : 365 - 371
  • [6] Clinical and Pathologic Supraclavicular Lymph Node Metastases in Esophageal Squamous Cell Carcinoma Treated by Esophagectomy with Three-Field Lymph Node Dissection
    Seong Yong Park
    Junghee Lee
    Yeong Jeong Jeon
    Jong Ho Cho
    Hong Kwan Kim
    Yong Soo Choi
    Jae Il Zo
    Young Mog Shim
    [J]. Annals of Surgical Oncology, 2024, 31 : 3399 - 3408
  • [7] Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection
    Chen, Junqiang
    Wu, Sangang
    Zheng, Xiongwei
    Pan, Jianji
    Zhu, Kunshou
    Chen, Yuanmei
    Li, Jiancheng
    Liao, Lianming
    Lin, Yu
    Liao, Zhongxing
    [J]. BMC SURGERY, 2014, 14
  • [8] Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection
    Junqiang Chen
    Sangang Wu
    Xiongwei Zheng
    Jianji Pan
    Kunshou Zhu
    Yuanmei Chen
    Jiancheng Li
    Lianming Liao
    Yu Lin
    Zhongxing Liao
    [J]. BMC Surgery, 14
  • [9] Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma
    Swanson, SJ
    Batirel, HF
    Bueno, R
    Jaklitsch, MT
    Lukanich, JM
    Allred, E
    Mentzer, SJ
    Sugarbaker, DJ
    [J]. ANNALS OF THORACIC SURGERY, 2001, 72 (06): : 1918 - 1924
  • [10] The Prognostic Relevance of Subcarinal Lymph Node Dissection in Esophageal Squamous Cell Carcinoma
    Niwa, Yukiko
    Koike, Masahiko
    Hattori, Masashi
    Iwata, Naoki
    Takami, Hideki
    Hayashi, Masamichi
    Tanaka, Chie
    Kobayashi, Daisuke
    Kanda, Mitsuro
    Yamada, Suguru
    Fujii, Tsutomu
    Nakayama, Goro
    Sugimoto, Hiroyuki
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (02) : 611 - 618